» Articles » PMID: 31965360

Synthesis and Characterization of Antibacterial Drug Loaded β-tricalcium Phosphate Powders for Bone Engineering Applications

Overview
Publisher Springer
Date 2020 Jan 23
PMID 31965360
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Powders of β-tricalcium phosphate [β-TCP, β-Ca(PO)] and composite powders of β-TCP and polyvinyl alcohol (PVA) were synthesized by using wet precipitation methods. First, the conditions for the preparation of single phase β-TCP have been delineated. In the co-precipitation procedure, calcium nitrate and diammonium hydrogen phosphate were used as calcium and phosphorous precursors, respectively. The pH of the system was varied in the range 7-11 by adding designed amounts of ammonia solution. The filtered cakes were desiccated at 80 °C and subsequently calcined at different temperatures in the range between 700-1100 °C. Later on, rifampicin form II was used to produce drug-loaded β-TCP and PVA/β-TCP powders. All the synthesized materials have been characterized from morphological (by scanning electron microscopy) and structural-chemical (by X-ray diffraction and Fourier transform infrared spectroscopy) point of view. The drug loading capacity of the selected pure β-TCP powder has been assessed. The biological performance (cytocompatibility in fibroblast cell culture and antibacterial efficacy against Escherichia coli and Staphylococcus aureus) has been tested with promising results. Application perspectives of the designed drug-bioceramic-polymer blends are advanced and discussed.

Citing Articles

Formulation of a Novel Polymeric Hydrogel Membrane for Periodontal Tissue Regeneration Using Tricalcium Phosphate-Alginate Reinforcement.

G S, P T P, Cecil A, S C, Suresh N Cureus. 2024; 16(4):e57844.

PMID: 38721191 PMC: 11078324. DOI: 10.7759/cureus.57844.


Composite Cement Materials Based on β-Tricalcium Phosphate, Calcium Sulfate, and a Mixture of Polyvinyl Alcohol and Polyvinylpyrrolidone Intended for Osteanagenesis.

Stepanova K, Lytkina D, Sadykov R, Shalygina K, Khojazoda T, Mahmadbegov R Polymers (Basel). 2023; 15(1).

PMID: 36616560 PMC: 9824037. DOI: 10.3390/polym15010210.


Sr and Mg Doped Bi-Phasic Calcium Phosphate Macroporous Bone Graft Substitutes Fabricated by Robocasting: A Structural and Cytocompatibility Assessment.

Besleaga C, Nan B, Popa A, Balescu L, Nedelcu L, Neto A J Funct Biomater. 2022; 13(3).

PMID: 36135559 PMC: 9502687. DOI: 10.3390/jfb13030123.


Surface coating of orthopedic implant to enhance the osseointegration and reduction of bacterial colonization: a review.

Bohara S, Suthakorn J Biomater Res. 2022; 26(1):26.

PMID: 35725501 PMC: 9208209. DOI: 10.1186/s40824-022-00269-3.


Composite Drug Delivery System Based on Amorphous Calcium Phosphate-Chitosan: An Efficient Antimicrobial Platform for Extended Release of Tetracycline.

Visan A, Ristoscu C, Popescu-Pelin G, Sopronyi M, Matei C, Socol G Pharmaceutics. 2021; 13(10).

PMID: 34683952 PMC: 8537227. DOI: 10.3390/pharmaceutics13101659.


References
1.
Mocanu A, Stan G, Maidaniuc A, Miculescu M, Antoniac I, Ciocoiu R . Naturally-Derived Biphasic Calcium Phosphates through Increased Phosphorus-Based Reagent Amounts for Biomedical Applications. Materials (Basel). 2019; 12(3). PMC: 6384751. DOI: 10.3390/ma12030381. View

2.
Lee J, Chang B, Jeung U, Park K, Kim M, Lee C . The first clinical trial of beta-calcium pyrophosphate as a novel bone graft extender in instrumented posterolateral lumbar fusion. Clin Orthop Surg. 2011; 3(3):238-44. PMC: 3162205. DOI: 10.4055/cios.2011.3.3.238. View

3.
Henwood S, Liebenberg W, Tiedt L, Lotter A, de Villiers M . Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates, and hydrates. Drug Dev Ind Pharm. 2002; 27(10):1017-30. DOI: 10.1081/ddc-100108364. View

4.
Gao P, Zhang H, Liu Y, Fan B, Li X, Xiao X . Beta-tricalcium phosphate granules improve osteogenesis in vitro and establish innovative osteo-regenerators for bone tissue engineering in vivo. Sci Rep. 2016; 6:23367. PMC: 4802206. DOI: 10.1038/srep23367. View

5.
Rahal E, Kazzi N, Kanbar A, Abdelnoor A, Matar G . Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice. Int J Antimicrob Agents. 2010; 37(2):135-9. DOI: 10.1016/j.ijantimicag.2010.10.009. View